BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31748534)

  • 1. Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases.
    Mundo L; Ambrosio MR; Raimondi F; Del Porro L; Guazzo R; Mancini V; Granai M; Jim Rocca B; Lopez C; Bens S; Onyango N; Nyagol J; Abinya N; Navari M; Ndede I; Patel K; Paolo Piccaluga P; Bob R; de Santi MM; Russell RB; Lazzi S; Siebert R; Stein H; Leoncini L
    Blood Cancer J; 2019 Nov; 9(12):91. PubMed ID: 31748534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
    De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
    BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
    Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
    Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
    Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior.
    McClure RF; Remstein ED; Macon WR; Dewald GW; Habermann TM; Hoering A; Kurtin PJ
    Am J Surg Pathol; 2005 Dec; 29(12):1652-60. PubMed ID: 16327438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
    Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
    Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.
    Salaverria I; Martin-Guerrero I; Wagener R; Kreuz M; Kohler CW; Richter J; Pienkowska-Grela B; Adam P; Burkhardt B; Claviez A; Damm-Welk C; Drexler HG; Hummel M; Jaffe ES; Küppers R; Lefebvre C; Lisfeld J; Löffler M; Macleod RA; Nagel I; Oschlies I; Rosolowski M; Russell RB; Rymkiewicz G; Schindler D; Schlesner M; Scholtysik R; Schwaenen C; Spang R; Szczepanowski M; Trümper L; Vater I; Wessendorf S; Klapper W; Siebert R; ;
    Blood; 2014 Feb; 123(8):1187-98. PubMed ID: 24398325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation.
    Rodig SJ; Vergilio JA; Shahsafaei A; Dorfman DM
    Am J Surg Pathol; 2008 Jan; 32(1):113-22. PubMed ID: 18162778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
    Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
    Ruzinova MB; Caron T; Rodig SJ
    Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2--an analysis including gene expression in formalin-fixed paraffin-embedded tissue.
    Masqué-Soler N; Szczepanowski M; Kohler CW; Aukema SM; Nagel I; Richter J; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2015 Nov; 171(4):501-8. PubMed ID: 26218299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive B-cell lymphomas: frequency, immunophenotype, and genetics in a reference laboratory population.
    Naeini YB; Wu A; O'Malley DP
    Ann Diagn Pathol; 2016 Dec; 25():7-14. PubMed ID: 27806850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
    Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
    Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
    J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of MYC rearrangement in high grade B cell lymphomas: correlation of MYC immunohistochemistry and FISH analysis.
    Lynnhtun K; Renthawa J; Varikatt W
    Pathology; 2014 Apr; 46(3):211-5. PubMed ID: 24614699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.